The raw material drug industry challenges the upgrade of related equipment companies to take the lead in the layout

[ Focus on Chemical Machinery and Equipment Network ] In early November, China’s two ministries and commissions jointly issued a notice on the "Implementation Plan for Promoting the High-quality Development of the API Industry".
Growing varieties, breaking through a batch of green and low-carbon technology and equipment, and vigorously developing characteristic APIs and innovative APIs
.

 

Judging from the direction indicated by the plan, green transformation and innovation and upgrading have become a major trend that promotes the high-quality development of the API industry
.
After the release of this plan, some organizations pointed out that although the policy has brought challenges and upgrades to the API industry, it is also good for leading companies in the API industry.
At the same time, the policy clearly encourages breakthroughs in a batch of green and low-carbon technology and equipment.
Equipment manufacturers that lay out green equipment are expected to usher in good news
.

 

The author has learned that, in fact, many domestic API equipment providers have already smelled the direction of industrial upgrading and are taking the lead in laying out on the new track in order to seize the market high ground in the field
.

 

On November 19th, Chutian Technology released two innovative overall solutions for aseptic products, one of which is an overall solution for aseptic freeze-dried API isolators to deal with the problem of APIs
.
According to reports, the overall solution of Chutian Technology’s aseptic freeze-dried API isolator is developed for the aseptic freeze-dried API market, which can realize the continuity of freeze-drying, discharging, crushing, mixing and sub-packaging processes, and isolate and seal the entire process.
, Automation, can help API users to meet the requirements of green and low-carbon, and ensure the quality of drug production
.
At the same time, the solution uses isolator technology to replace the traditional open manufacturing, which is conducive to reducing the user's operation and maintenance costs, and reducing the impact of dust diffusion on the environment and personnel
.

 

The innovative advantages of this solution are undoubtedly of great significance for the high-quality development of the API industry and the cost control of pharmaceutical companies
.
On the one hand, after the technology upgrade of freeze dryer and API equipment, it will promote the high-quality development of the freeze-dried API industry; on the other hand, through the application of isolator technology, it will help reduce the operating costs of pharmaceutical companies and ensure the aseptic production of drugs.
To protect the occupational health of personnel
.
For the company, the introduction of new solutions is also expected to bring new growth points to the company
.

 

In addition, many pharmaceutical machinery companies have actively launched innovative actions in order to cooperate with the upgrading of raw material pharmaceutical companies under the requirements of energy saving, consumption reduction, pollution reduction, and efficiency enhancement in the API industry
.
For example, some drying equipment manufacturers optimize product design and create green equipment by setting up special environmental protection companies and supporting engineering experiment centers; there are also pharmaceutical machinery companies that integrate new technologies into the R&D and production of API equipment , and develop the use of liquid nitrogen.
The liquid nitrogen freeze dryer used as a cold source to cool the system greatly reduces energy consumption and water consumption
.

 

　　In addition, intelligence is becoming a new means of reducing costs and increasing efficiency in the API industry
.
It is reported that some API companies have actively promoted intelligent production as early as the second half of 2020.
The product yield after the transformation has been further improved, and the production safety is more reliable, which greatly reduces the production and operation costs, and steadily improves the product quality.
The improvement of the flat production management level reduces the deviation of human operation errors
.
It is reported that after the completion of the pharmaceutical factory, the production line will intelligently cover the entire process, and the commissioning rate will reach more than 90%
.

 

　　Original title: The raw material medicine industry challenges the upgrade of related equipment companies to take the lead in the layout